Fmr LLC raised its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 18.5% during the third quarter, HoldingsChannel.com reports. The fund owned 6,499,139 shares of the medical research company’s stock after buying an additional 1,016,082 shares during the period. Fmr LLC’s holdings in Thermo Fisher Scientific were worth $1,586,310,000 at the end of the most recent reporting period.
Other large investors have also bought and sold shares of the company. BlackRock Inc. grew its position in shares of Thermo Fisher Scientific by 0.9% during the third quarter. BlackRock Inc. now owns 25,233,243 shares of the medical research company’s stock valued at $6,158,932,000 after purchasing an additional 226,824 shares in the last quarter. Wells Fargo & Company MN grew its position in shares of Thermo Fisher Scientific by 0.7% during the third quarter. Wells Fargo & Company MN now owns 3,213,226 shares of the medical research company’s stock valued at $784,285,000 after purchasing an additional 23,811 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Thermo Fisher Scientific by 3.2% during the second quarter. Dimensional Fund Advisors LP now owns 2,670,961 shares of the medical research company’s stock valued at $553,246,000 after purchasing an additional 82,255 shares in the last quarter. Janus Henderson Group PLC grew its position in shares of Thermo Fisher Scientific by 1.7% during the second quarter. Janus Henderson Group PLC now owns 2,036,659 shares of the medical research company’s stock valued at $421,880,000 after purchasing an additional 34,401 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. grew its position in shares of Thermo Fisher Scientific by 3.1% during the second quarter. Schwab Charles Investment Management Inc. now owns 1,566,563 shares of the medical research company’s stock valued at $324,498,000 after purchasing an additional 46,519 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.
In other Thermo Fisher Scientific news, Director Tyler Jacks sold 4,772 shares of the business’s stock in a transaction that occurred on Monday, November 19th. The stock was sold at an average price of $239.75, for a total transaction of $1,144,087.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Marc N. Casper sold 125,520 shares of the business’s stock in a transaction that occurred on Monday, October 1st. The shares were sold at an average price of $247.50, for a total value of $31,066,200.00. The disclosure for this sale can be found here. Company insiders own 0.49% of the company’s stock.
TMO opened at $233.02 on Friday. The stock has a market capitalization of $93.81 billion, a P/E ratio of 24.55, a P/E/G ratio of 1.69 and a beta of 1.08. Thermo Fisher Scientific Inc. has a 12 month low of $181.51 and a 12 month high of $249.95. The company has a quick ratio of 1.27, a current ratio of 1.84 and a debt-to-equity ratio of 0.66.
Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, October 24th. The medical research company reported $2.62 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.55 by $0.07. The company had revenue of $5.92 billion during the quarter, compared to analyst estimates of $5.70 billion. Thermo Fisher Scientific had a return on equity of 16.49% and a net margin of 10.75%. The firm’s revenue was up 15.7% on a year-over-year basis. During the same quarter last year, the business posted $2.31 earnings per share. Analysts anticipate that Thermo Fisher Scientific Inc. will post 11.04 earnings per share for the current year.
Thermo Fisher Scientific declared that its Board of Directors has initiated a stock buyback plan on Friday, September 7th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the medical research company to reacquire up to 2.1% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, January 15th. Investors of record on Monday, December 17th will be given a $0.17 dividend. The ex-dividend date of this dividend is Friday, December 14th. This represents a $0.68 annualized dividend and a yield of 0.29%. Thermo Fisher Scientific’s dividend payout ratio is currently 7.17%.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Further Reading: Find a Trading Strategy That Works
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.